AGI
CC icon

Athena Global Investors’s Chemours CC Stock Holding History

Athena Global Investors’s Portfolio CC Stock Details CC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-4,007
Closed -$33K – 33
2016
Q2 		$33K Sell
4,007
-2,203
-35% -$19.6K 0.05% 33
2016
Q1 		$43K Hold
6,210
– – 0.04% 32
2015
Q4 		$33K Hold
6,210
– – 0.03% 35
2015
Q3 		$40K Buy
+6,210
New +$65K 0.04% 34

Other funds holding CC

GC
Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $1.92B AUM 70.51% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCM
Gates Capital Management New York $4.16B AUM 21% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $5.02B AUM 66.06% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Athena Global Investors's CC Position: Q3 2016 in Review

Athena Global Investors sold out of Chemours (CC) in Q3 2016, closing a stake of 4,007 shares — an estimated $33K sold.

Athena Global Investors first reported a position in CC in Q3 2015 and held it in 4 quarters. The position peaked at $43K in Q1 2016. 379 funds tracked by Wall St. Rank hold CC as of Q3 2016.

  • Athena Global Investors reported no remaining Chemours position as of Q3 2016 after selling out during the quarter.
  • Athena Global Investors sold 4,007 Chemours shares in Q3 2016, an estimated $33K.
  • Athena Global Investors first reported a position in Chemours in Q3 2015 and held it in 4 quarters.
  • Athena Global Investors's Chemours position peaked at $43K in Q1 2016.
  • 379 funds tracked by Wall St. Rank held Chemours as of Q3 2016.

Based on Athena Global Investors's 13F filing for Q3 2016, filed 14 Nov 2016.